On-demand Webinar – AI & Multi-omics for Translational…
Innovations driving drug discovery breakthroughs and shaping future-ready strategies The most transformative breakthroughs are emerging at the intersection of AI,…
Why Multi-Omic Insights Demand a Multi-Omic Strategy
A Precision Approach to Interrogate Markers that Matter Multi-omics can unlock critical insight into disease biology and treatment response—but only…
إدراج شركة SHELT ضمن قائمة MSSP 250 لعام 2025
قبرص – (ARAB NEWSWIRE) — أُدرجت شركة SHELT، المتخصصة في تقديم خدمات الأمن السيبراني كخدمة، ضمن قائمة MSSP 250 لعام 2025،…
A Guide for CGT Developers in Switching CDMO Partners
This playbook is a how-to guide in assessing potential CDMOs when initiating a switch to a new secondary or primary…
Advancing T Cell Immunotherapy Research: The Power of…
eBook Adoptive cell therapies such as chimeric antigen receptor (CAR) T lymphocytes and other T cell-based modalities are reshaping the…
Decision-Ready Proteomics for Modern Drug Discovery
Our latest white paper reveals how industrial-scale, mass spectrometry-based proteomics can help you accelerate discovery, reduce risk, and unlock new therapeutic…